scholarly journals The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications

2021 ◽  
pp. 107863
Author(s):  
Koichiro Kuwahara
Circulation ◽  
1997 ◽  
Vol 96 (2) ◽  
pp. 509-516 ◽  
Author(s):  
Takayoshi Tsutamoto ◽  
Atsuyuki Wada ◽  
Keiko Maeda ◽  
Tomoko Hisanaga ◽  
Yukiharu Maeda ◽  
...  

2017 ◽  
Vol 63 (1) ◽  
pp. 50-58 ◽  
Author(s):  
Vlad C Vasile ◽  
Allan S Jaffe

Abstract BACKGROUND The natriuretic peptide system is an endocrine, autocrine and paracrine system that plays an important role in the maintenance of cardiovascular homeostasis. Biomarkers based on these peptides are important diagnostic and prognostic tools for myocardial function. CONTENT Although natriuretic peptides were discovered more than 2 decades ago, their intricate and complex biology is associated with important questions not yet elucidated. The diversity of circulating forms of natriuretic peptides, the distinct expression of these forms in particular patients, and the heterogeneity of heart failure forms, along with specific assay-related and preanalytic issues, cause assays to be poorly harmonized. SUMMARY This review presents the relevant issues related to the biology of natriuretic peptides and differences between assays with immediate implications for clinical practice.


2009 ◽  
Vol 10 (1) ◽  
pp. 39-43 ◽  
Author(s):  
Patrícia Lourenço ◽  
Ana Azevedo ◽  
José Paulo Araújo ◽  
Paulo Bettencourt

2004 ◽  
Vol 102 (3) ◽  
pp. 223-241 ◽  
Author(s):  
Zaid Abassi ◽  
Tony Karram ◽  
Samer Ellaham ◽  
Joseph Winaver ◽  
Aaron Hoffman

2003 ◽  
Vol 105 (2) ◽  
pp. 141-160 ◽  
Author(s):  
Matthias SCHMITT ◽  
John R. COCKCROFT ◽  
Michael P. FRENNEAUX

Since the discovery of atrial natriuretic peptide, the unravelling of the natriuretic peptide system has been a story of scientific success. However, bridging the gap between bench and bedside has proved difficult, and as yet has not provided any major clinical progress. In this review we will first give a detailed outline of the key elements constituting the natriuretic peptide system. Secondly, we will briefly explain the underlying rationale, basic concepts and evidence behind currently pursued strategies to potentiate the natriuretic peptide system. Thirdly, we will highlight some of the problems that have so far hindered successful translation of these theoretically viable treatment options into tangible clinical progress.


Circulation ◽  
2002 ◽  
Vol 105 (8) ◽  
pp. 999-1003 ◽  
Author(s):  
Horng H. Chen ◽  
John G. Lainchbury ◽  
Gail J. Harty ◽  
John C. Burnett

Circulation ◽  
1993 ◽  
Vol 88 (3) ◽  
pp. 1004-1009 ◽  
Author(s):  
C M Wei ◽  
D M Heublein ◽  
M A Perrella ◽  
A Lerman ◽  
R J Rodeheffer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document